Login to Your Account



Financings Roundup

Trius Decreases Size of IPO Deal from $78M to $49M

By Catherine Hollingsworth


Tuesday, August 3, 2010
After delaying its initial public offering earlier this year, Trius Therapeutics Inc. said Monday that it now plans to decrease the size of its proposed IPO deal. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription